Innoviva Strategic Opportunities LLC, Ten Percent Owner Other at Entasis Therapeutics Holdings Inc. (ETTX), bought 38,540,952 shares at $2.20 ($84.8M) on 2022-07-11, disclosed to the SEC on 2022-07-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 11,671,662 | $25.7M | 30.3% |
| 2 | $2.20 | 11,671,662 | $25.7M | 30.3% |
| 3 | $2.20 | 7,598,814 | $16.7M | 19.7% |
| 4 | $2.20 | 7,598,814 | $16.7M | 19.7% |
| Total | $2.20 avg | 38,540,952 | $84.8M | 100% |
| Filing → |
| ETTX | BUY | 2021-06-11 | $12.5M | — | Filing → |
| ARMP | BUY | 2021-01-28 | $6.1M | — | Filing → |